lactams - CISMeF

Preferred Label : lactams;

MeSH definition : Cyclic AMIDES formed from aminocarboxylic acids by the elimination of water. Lactims are the enol forms of lactams.;

MeSH synonym : Lactam;

MeSH hyponym : lactims; Lactim;

Wikipedia link : https://en.wikipedia.org/wiki/Lactam;

Is substance : O;

Details

Origin ID

D007769;

UMLS CUI

C0022914;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Lactam (substance) [SNOMED CT concept]
- lactams [IUPAC Term]
Indexing information
- gamma-lactam(11) human growth hormone (6-13) [MeSH Supplementary Concept]
Pharmacological action(s)
- anti-bacterial agents [MeSH Descriptor]
Record concept(s)
- lactams [MeSH concept]
- lactims [MeSH concept]
Related MeSH Supplementary Concept(s)
- (1'R,5R,6R)-3-(4-amino-1,1-dimethyl-butyl)-6-(1'-hydroxyethyl)oxapenem-3-carboxylate [MeSH Supplementary Concept]
- (2S,3R)-3-((2-aminopyridin-4-yl)methyl)-1-(((1R)-1-cyclohexylethyl) carbamoyl)-4-oxoazetidine-2-carboxylic acid [MeSH Supplementary Concept]
- (3S)-3-((N-(4-methoxy-1H-indole-2-carbonyl)-L-leucyl)amino)-2-oxo-4-((3S)-2-oxopiperidin-3-yl)butyl 2,4,6-trimethylpyridine-3-carboxylate [MeSH Supplementary Concept]
- (5-dimethylaminocarbonylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)penem-3-carboxylic acid [MeSH Supplementary Concept]
- 1,3,4,5,6,7,8,10-octahydro-14-hydroxy-12-methoxy-11-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-9,2,5-benzoxanthiaazacyclododecine-10-one [MeSH Supplementary Concept]
- 1,3,4,5,6,7,8,9,10,12-decahydro-16-hydroxy-14-methoxy-13-methyl-4-(3-methyl-1,2,4-oxadiazol-5-yl)-6-thioxo-11,2,5-benzoxathiaazacyclotetradecine-12-one [MeSH Supplementary Concept]
- 1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide [MeSH Supplementary Concept]
- 1-azabicyclo(5.2.0)nonan-2-one lactam [MeSH Supplementary Concept]
- 1-hexylindolactam-V10 [MeSH Supplementary Concept]
- 1-methyl-4-phenyl-5,6-dihydro-2-pyridone [MeSH Supplementary Concept]
- 11-epi-awajanomycin [MeSH Supplementary Concept]
- 14-deoxy-9-oxygigantecin [MeSH Supplementary Concept]
- 17,18-dihydro-5H,9H-dibenzo(e,n)(1,4,10,7,13)trioxadiazacyclopentadecine-6,10(7H,11H)-dione [MeSH Supplementary Concept]
- 2,2-dimethylpenam sulfone [MeSH Supplementary Concept]
- 2-((1-phenacylpyrrolidin-3-yl)thio)-6-(1-hydroxypropyl)penem-3-carboxylic acid [MeSH Supplementary Concept]
- 2-((pyrrolidin-3-yl)thio)-6-(1-hydroxypropyl)penem-3-carboxylic acid [MeSH Supplementary Concept]
- 2-(2-((13-amino-2-(4-hydroxybenzyl)-3,14-dioxo-1,4-diazacyclotetradec-7-ene-5-carboxamido)methyl)phenyl)acetic acid [MeSH Supplementary Concept]
- 2-(2-fluoroethylthio)-6-(1-hydroxyethyl)penem-3-carboxylate [MeSH Supplementary Concept]
- 2-amino-2-deoxy-D-xylothionolactam [MeSH Supplementary Concept]
- 2-azabicyclo(2.2.1)hept-5-en-3-one [MeSH Supplementary Concept]
- 2-chloromethyl-6-carbamoylmethylpenam-1,1-dioxide-3-carboxylic acid [MeSH Supplementary Concept]
- 20R-15,20-dihydrocleavamine [MeSH Supplementary Concept]
- 3,3-diethyl-2-pyrrolidinone [MeSH Supplementary Concept]
- 3,3-pentamethylene-4-butyrolactam [MeSH Supplementary Concept]
- 3-(2-cyanoethenyl)-3-methyl-4,4,7-trioxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid [MeSH Supplementary Concept]
- 3-acetoxymethyl-7-chloro-3-cephem-4-carboxylate-1,1-dioxide tert-butylester [MeSH Supplementary Concept]
- 3-amino-2-indolyllactam [MeSH Supplementary Concept]
- 3-oxo-rhazinilam [MeSH Supplementary Concept]
- 4,5-dithiaheptane-7-lactam [MeSH Supplementary Concept]
- 4-(5-((1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino)methyl)imidazol-1-ylmethyl)benzonitrile [MeSH Supplementary Concept]
- 4-acetoxy-3-(1'-((tert-butyldimethylsilyl)oxy)ethyl)-2-azetidinone [MeSH Supplementary Concept]
- 4-oxa-1-azabicyclo(3.2.0)heptan-7-one [MeSH Supplementary Concept]
- 5-chloro-armeniaspirole A [MeSH Supplementary Concept]
- 5-methoxyaristololactam I [MeSH Supplementary Concept]
- 6,7,9,10-tetrahydro-16H,20H-dibenzo(h,q)1,4,7,13,10,16-tetraoxadiazacyclooctadecine-27,21(18H,22H)-dione [MeSH Supplementary Concept]
- 6-(1-hydroxyethyl)-2-isopropyl-1-oxa-penem-3-carboxylic acid [MeSH Supplementary Concept]
- 6-(1-hydroxyethyl)-2-methyl-1-oxa-2-penem-3-carboxylic acid [MeSH Supplementary Concept]
- 6-(1-hydroxyethyl)-2-phenyl-1-oxa-2-penem-3-carboxylic acid [MeSH Supplementary Concept]
- 6-alpha-hydroxyethyl-2-acetoxymethyl-2-penem-3-carboxylic acid [MeSH Supplementary Concept]
- 6-bromo-indolactam V [MeSH Supplementary Concept]
- 6-desmethyl-N-methylfluvirucin A1 [MeSH Supplementary Concept]
- 6-hydroxy- 8-(1-decynyl)-benzolactam-V8 [MeSH Supplementary Concept]
- 6-hydroxyl-clausenamide [MeSH Supplementary Concept]
- 6-n-octyl-indolactam V [MeSH Supplementary Concept]
- 7,16,19-triaza-18-carbamoylmethyl-9-carboxymethyl-14-((5-methylindol-1-yl)methyl)-8,17,20-trioxo-10-(4-phosphonomethylphenyl)spiro(5.14)eicos-11-ene [MeSH Supplementary Concept]
- 7,7-dimethyl-5H-dibenzo(e,i)(1,4,8)triazacycloundecine-6,9,15-(7H,8H,14H)-trione [MeSH Supplementary Concept]
- 7-((N(5)-acetyl-N(5)-hydroxyornithyl-N(5)-acetyl-N(5)-hydroxyornithyl-N(5)-acetyl-N(5)-hydroxyornithyl-phenylglycyl)amino)-1-carba-3-chloro-3-cephem-4-carboxylic acid [MeSH Supplementary Concept]
- 7-((N(5)acetyl-N(5)-hydroxyornithyl-N(5)acetyl-N(5)hydroxyornithyl-N(5)-acetyl-N(5)-hydroxyornithyl-4-hydroxyphenylglycyl)amino)-3-chloro-1-carba-3-cephem-4-carboxylic acid [MeSH Supplementary Concept]
- 7-amino-3-hydroxycepham-4-carboxylic acid [MeSH Supplementary Concept]
- 7-amino-3-methylenecepham-4-carboxylic acid [MeSH Supplementary Concept]
- 7-geranylindolactam V [MeSH Supplementary Concept]
- 7-hydroxy-clausenamide [MeSH Supplementary Concept]
- 7-hydroxyethyl-1-oxacephem [MeSH Supplementary Concept]
- 7-octylindolactam V [MeSH Supplementary Concept]
- 7-phenylacetyl cephalosporin [MeSH Supplementary Concept]
- 8,4'-dideshydroxy-leinamycin [MeSH Supplementary Concept]
- 8-hydroxyircinialactam A [MeSH Supplementary Concept]
- 8-octylbenzolactam-V9 [MeSH Supplementary Concept]
- 9,10,20,21-tetrahydro-5H,12H-dibenzo(e,q)(1,4,10.13,7,16)tetraoxadiazacyclooctadecine-6,13(7H,14H)-dione [MeSH Supplementary Concept]
- 9-methoxycanthin-6-one [MeSH Supplementary Concept]
- ABT 281 [MeSH Supplementary Concept]
- AM 113 [MeSH Supplementary Concept]
- AM 114 [MeSH Supplementary Concept]
- AM 115 [MeSH Supplementary Concept]
- BE 14106 [MeSH Supplementary Concept]
- BLI-489 [MeSH Supplementary Concept]
- BMS 269223 [MeSH Supplementary Concept]
- BMY 26225 [MeSH Supplementary Concept]
- BO 2669 [MeSH Supplementary Concept]
- C6-(N1-methyl-1,2,3-trazolylmethylene)penem [MeSH Supplementary Concept]
- CCF 2 [MeSH Supplementary Concept]
- CGP 31608 [MeSH Supplementary Concept]
- CP 65207 [MeSH Supplementary Concept]
- DLAM-1P compound [MeSH Supplementary Concept]
- FCE 22891 [MeSH Supplementary Concept]
- FCE 24362 [MeSH Supplementary Concept]
- FR 182024 [MeSH Supplementary Concept]
- FR 252921 [MeSH Supplementary Concept]
- GC376 [MeSH Supplementary Concept]
- GT32-B [MeSH Supplementary Concept]
- GV 104326 [MeSH Supplementary Concept]
- GV 129606 [MeSH Supplementary Concept]
- GV143253A [MeSH Supplementary Concept]
- HRE 664 [MeSH Supplementary Concept]
- IDX375 [MeSH Supplementary Concept]
- IK 682 [MeSH Supplementary Concept]
- JAM 2-263 [MeSH Supplementary Concept]
- JBIR-15 [MeSH Supplementary Concept]
- KBH-A145 [MeSH Supplementary Concept]
- KI-MS2-008 [MeSH Supplementary Concept]
- L 680833 [MeSH Supplementary Concept]
- L 700653 [MeSH Supplementary Concept]
- L 786392 [MeSH Supplementary Concept]
- L-755,807 [MeSH Supplementary Concept]
- LY 275858 [MeSH Supplementary Concept]
- LY 312340 [MeSH Supplementary Concept]
- MC-02,331 [MeSH Supplementary Concept]
- N-(2''-hydroxy-2''-(4-hydroxy-16-oxo-7,8,9,10,11,12,13,14,15,16-decahydro-6H-5-oxa-15-azabenzocyclotetradecen-14-yl)ethyl)-N-isobutyl-4-methoxybenzenesulfonamide [MeSH Supplementary Concept]
- N-(phenylthio)-epsilon-caprolactam [MeSH Supplementary Concept]
- N-Fmoc-(2S,3S,4R)-3,4-dimethylglutamine [MeSH Supplementary Concept]
- N-methylfluvirucin A1 [MeSH Supplementary Concept]
- NB 216 [MeSH Supplementary Concept]
- OPC 20011 [MeSH Supplementary Concept]
- P-Rhod compound [MeSH Supplementary Concept]
- PF-5236216 [MeSH Supplementary Concept]
- PHX1766 [MeSH Supplementary Concept]
- PI-090 [MeSH Supplementary Concept]
- PI-091 [MeSH Supplementary Concept]
- Q-1047H-A-A [MeSH Supplementary Concept]
- Q-1047H-R-A [MeSH Supplementary Concept]
- RWJ-333441 [MeSH Supplementary Concept]
- SB 216357 [MeSH Supplementary Concept]
- SB-212047 [MeSH Supplementary Concept]
- SB-216477 [MeSH Supplementary Concept]
- SB-216754 [MeSH Supplementary Concept]
- SBI-0640756 [MeSH Supplementary Concept]
- SC 903 [MeSH Supplementary Concept]
- SCH 42282 [MeSH Supplementary Concept]
- SE 205 [MeSH Supplementary Concept]
- SQ 28504 [MeSH Supplementary Concept]
- SQ 28546 [MeSH Supplementary Concept]
- SYN 1012 [MeSH Supplementary Concept]
- T 5578 [MeSH Supplementary Concept]
- U 78608 [MeSH Supplementary Concept]
- aburatubolactam C [MeSH Supplementary Concept]
- allyl 6-(1'-acetoxyethyl)penem-3-carboxylate [MeSH Supplementary Concept]
- allyl 6-(1'-hydroxyethyl)penem-3-carboxylate [MeSH Supplementary Concept]
- allyl-6-(acetoxyethyl)-penem-3-carboxylate [MeSH Supplementary Concept]
- alpha-oxo-gamma-butyrolactam [MeSH Supplementary Concept]
- angiolam A [MeSH Supplementary Concept]
- antibiotic PS 8 [MeSH Supplementary Concept]
- antiprotealide [MeSH Supplementary Concept]
- aphelandrine [MeSH Supplementary Concept]
- aristolactam AIIIa [MeSH Supplementary Concept]
- aristolactam BII [MeSH Supplementary Concept]
- aristolactam E [MeSH Supplementary Concept]
- aristolactam GI [MeSH Supplementary Concept]
- aristolactam-AIIIa-6-O-beta-D-glucoside [MeSH Supplementary Concept]
- aureoverticillactam [MeSH Supplementary Concept]
- awajanomycin [MeSH Supplementary Concept]
- azazerumbone [MeSH Supplementary Concept]
- benz(cd)indol-2(1H)-one [MeSH Supplementary Concept]
- benzolactam V8-310 [MeSH Supplementary Concept]
- beta-caprolactam [MeSH Supplementary Concept]
- bisavenanthramide B-6 [MeSH Supplementary Concept]
- blastmycetin F [MeSH Supplementary Concept]
- carbapenam-3-carboxylic acid [MeSH Supplementary Concept]
- cephalimysin B [MeSH Supplementary Concept]
- cephalimysin C [MeSH Supplementary Concept]
- cephalimysin D [MeSH Supplementary Concept]
- chlorocardicin [MeSH Supplementary Concept]
- cladosporilactam A [MeSH Supplementary Concept]
- clausenamide [MeSH Supplementary Concept]
- cordioxime [MeSH Supplementary Concept]
- cremimycin [MeSH Supplementary Concept]
- cryptophycin 175 [MeSH Supplementary Concept]
- cryptophycin 176 [MeSH Supplementary Concept]
- cryptophycin 46 [MeSH Supplementary Concept]
- cryptophycin 52 [MeSH Supplementary Concept]
- cryptophycin 8 [MeSH Supplementary Concept]
- cyclamenol A [MeSH Supplementary Concept]
- cyclamenol C [MeSH Supplementary Concept]
- cytoblastin [MeSH Supplementary Concept]
- danoprevir [MeSH Supplementary Concept]
- desferrioxamine E [MeSH Supplementary Concept]
- dietziamide A [MeSH Supplementary Concept]
- dietziamide B [MeSH Supplementary Concept]
- dihydromaltophilin [MeSH Supplementary Concept]
- dihydroxyverbacine [MeSH Supplementary Concept]
- divaricataester A [MeSH Supplementary Concept]
- enterocarpam-III [MeSH Supplementary Concept]
- fluvirucin A1 [MeSH Supplementary Concept]
- fluvirucin B1 [MeSH Supplementary Concept]
- fluvirucin B2 [MeSH Supplementary Concept]
- fluvirucinine A1 [MeSH Supplementary Concept]
- formadicin [MeSH Supplementary Concept]
- fusarin X [MeSH Supplementary Concept]
- fusarin Z [MeSH Supplementary Concept]
- glorin [MeSH Supplementary Concept]
- hapalosin [MeSH Supplementary Concept]
- hemerocallisamine III [MeSH Supplementary Concept]
- hericerin [MeSH Supplementary Concept]
- holomycin [MeSH Supplementary Concept]
- ikarugamycin [MeSH Supplementary Concept]
- incednine [MeSH Supplementary Concept]
- indolactam V [MeSH Supplementary Concept]
- ircinialactam A [MeSH Supplementary Concept]
- ircinialactam C [MeSH Supplementary Concept]
- isomethoxyneihumicin [MeSH Supplementary Concept]
- laevicarpin [MeSH Supplementary Concept]
- lajollamycin [MeSH Supplementary Concept]
- lansimide 2 [MeSH Supplementary Concept]
- laurolactam [MeSH Supplementary Concept]
- leinamycin [MeSH Supplementary Concept]
- lorlatinib [MeSH Supplementary Concept]
- maltophilin [MeSH Supplementary Concept]
- mannonic-delta-lactam [MeSH Supplementary Concept]
- marinamide [MeSH Supplementary Concept]
- men 10700 [MeSH Supplementary Concept]
- methyl 6-epi-cucurbate [MeSH Supplementary Concept]
- methylpendolmycin [MeSH Supplementary Concept]
- mirabilin (macrolide lactam) [MeSH Supplementary Concept]
- monascustin [MeSH Supplementary Concept]
- morpholinoethyl 10-(1-hydroxyethyl)-4-methoxy-11-oxoazatricyclo(7.2.0.0(3,8))undec-2-encarboxylate [MeSH Supplementary Concept]
- muramic lactam [MeSH Supplementary Concept]
- nacubactam [MeSH Supplementary Concept]
- naphthomycinol [MeSH Supplementary Concept]
- nirmatrelvir [MeSH Supplementary Concept]
- nirmatrelvir and ritonavir drug combination [MeSH Supplementary Concept]
- nocardicin [MeSH Supplementary Concept]
- olivacins [MeSH Supplementary Concept]
- olivanic acid [MeSH Supplementary Concept]
- p53 activator SYNAP [MeSH Supplementary Concept]
- paraphaeosphaeride A [MeSH Supplementary Concept]
- paraphaeosphaeride B [MeSH Supplementary Concept]
- paraphaeosphaeride C [MeSH Supplementary Concept]
- paraphaeosphaeride D [MeSH Supplementary Concept]
- pauciflorine A [MeSH Supplementary Concept]
- pauciflorine B [MeSH Supplementary Concept]
- phenylmethyl N-((1S)-1-((((1S)-1-formyl-2-(2-oxo-3-pyrrolidinyl)ethyl)amino)carbonyl)-3-methylbutyl)carbamate [MeSH Supplementary Concept]
- piperlactam S [MeSH Supplementary Concept]
- piplaroxide [MeSH Supplementary Concept]
- poecillastrin A [MeSH Supplementary Concept]
- poecillastrin B [MeSH Supplementary Concept]
- poecillastrin C [MeSH Supplementary Concept]
- poecillastrin D [MeSH Supplementary Concept]
- poly(N-vinylprolactam) [MeSH Supplementary Concept]
- pramanicin [MeSH Supplementary Concept]
- pulchellalactam [MeSH Supplementary Concept]
- pyridinium, 2-(((2-carboxy-6-(1-hydroxyethyl)-7-oxo-1-azabicyclo(3.2.0)hept-2-en-3-yl)thio)methyl)-1-methyl-, hydroxide, inner salt, (5R-(5.alpha.,6.alpha.(R*)))- [MeSH Supplementary Concept]
- rhazinilam [MeSH Supplementary Concept]
- ripromycin [MeSH Supplementary Concept]
- robotnikinin [MeSH Supplementary Concept]
- salinosporamide B [MeSH Supplementary Concept]
- salinosporamide C [MeSH Supplementary Concept]
- salinosporamide K [MeSH Supplementary Concept]
- sanfetrinem [MeSH Supplementary Concept]
- sanfetrinem cilexetil [MeSH Supplementary Concept]
- sauristolactam [MeSH Supplementary Concept]
- sch 29482 [MeSH Supplementary Concept]
- sch 33440 [MeSH Supplementary Concept]
- sch 34343 [MeSH Supplementary Concept]
- schulzeine B [MeSH Supplementary Concept]
- schulzeine C [MeSH Supplementary Concept]
- silvalactam [MeSH Supplementary Concept]
- stemona-lactam S [MeSH Supplementary Concept]
- sulopenem [MeSH Supplementary Concept]
- tedanalactam [MeSH Supplementary Concept]
- terramide A [MeSH Supplementary Concept]
- tetralactam macrocycle [MeSH Supplementary Concept]
- thiaisatoic anhydride [MeSH Supplementary Concept]
- thiomarinol D [MeSH Supplementary Concept]
- thiomarinol E [MeSH Supplementary Concept]
- thiomarinol F [MeSH Supplementary Concept]
- thiomarinol g [MeSH Supplementary Concept]
- topostatin [MeSH Supplementary Concept]
- tricatechol hexalactam-bismuth(III) complex [MeSH Supplementary Concept]
- tricatechol hexalactam-lead(II) complex [MeSH Supplementary Concept]
- trichoderamide A [MeSH Supplementary Concept]
- trichoderamide B [MeSH Supplementary Concept]
- tripartilactam [MeSH Supplementary Concept]
- triticone A [MeSH Supplementary Concept]
- triticone C [MeSH Supplementary Concept]
- tuberostemospiroline [MeSH Supplementary Concept]
- valerolactam [MeSH Supplementary Concept]
- verticilactam [MeSH Supplementary Concept]
- vicenistatin [MeSH Supplementary Concept]
- vicenistatin M [MeSH Supplementary Concept]
- virgaricin B [MeSH Supplementary Concept]
- viridinomycin [MeSH Supplementary Concept]
See also inter- (CISMeF)
- lactims [IUPAC Term]
Semantic type(s)
- Antibiotic [UMLS semantic type]
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- Lactam (substance) [SNOMED CT concept]
Validated automatic mappings to BTNT
- Beta-lactam (substance) [SNOMED CT concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients